Skip to content

Clinical study on oral squamous cell carcinoma patients with malnutrition

Clinical study on oral squamous cell carcinoma patients with malnutrition

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs071230055
Enrollment
20
Registered
2023-08-29
Start date
2023-11-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral squamous cell carcinoma

Interventions

To investigate the improvement of postoperative prognostic nutritional status (PNI) in patients with oral squamous cell carcinoma.

Sponsors

Suzuki Hajime
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adults over 18 years of age with a diagnosis of first oral squamous cell carcinoma for which surgery is indicated 2. Approximately anxiety or fatigue fatigue or anemia (HB <14g/dl, female 12g/dl) 3. Those who can take the test drug (including tube administration) within one week after surgery 4. Those who have obtained the consent of participation in this exam by writing

Exclusion criteria

Exclusion criteria: 1. Those who cannot consume food and oral agents and digested and absorb 2. Those who are recognized for a decrease in obvious cognitive function 3. Patients who plan to provide postoperative chemotherapy and radiation therapy 4. Those who have been taking Kampo preparations within the past 2 weeks 5. Those who are using Anamorelin or are planning to use 6. Patient who was determined to be inappropriate due to the discretion of the researcher

Design outcomes

Primary

MeasureTime frame
Change in postoperative PNI

Secondary

MeasureTime frame
NLR, LMR, PLR, GPS, CONUT, Body weight, short-term nutritional index

Contacts

Public ContactHajime Suzuki

Kagoshima University Hospital

hajime@dent.kagoshima-u.ac.jp+81-99-275-6242

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Aug 16, 2026